Tuberous Sclerosis: A New Frontier in Targeted Treatment of Autism - Wikidata - thesis-toulmin - TriplyDB

Tuberous Sclerosis: A New Frontier in Targeted Treatment of Autism

Tuberous Sclerosis: A New Frontier in Targeted Treatment of Autism

http://www.wikidata.org/entity/Q35811772

about

Genetic Syndromes, Maternal Diseases and Antenatal Factors Associated with Autism Spectrum Disorders (ASD)Everolimus improves neuropsychiatric symptoms in a patient with tuberous sclerosis carrying a novel TSC2 mutation Advances and Future Directions for Tuberous Sclerosis Complex Research: Recommendations From the 2015 Strategic Planning Conference.Genetic Animal Models for Autism Spectrum Disorder.Defective phosphoinositide metabolism in autism.Symptom profiles of autism spectrum disorder in tuberous sclerosis complex.Therapeutic Advances in Autism and Other Neurodevelopmental Disorders.mGluR5 Modulation of Behavioral and Epileptic Phenotypes in a Mouse Model of Tuberous Sclerosis Complex.Nuclear Excluded Autism-Associated Phosphatase and Tensin Homolog Mutations Dysregulate Neuronal Growth.Early autism symptoms in infants with tuberous sclerosis complex.The de novo autism spectrum disorder RELN R2290C mutation reduces Reelin secretion and increases protein disulfide isomerase expression.Presentation and Diagnosis of Tuberous Sclerosis Complex in Infants.The Way Forward for Mechanism-Based Therapeutics in Genetically Defined Neurodevelopmental Disorders

P2860

Q26741618-2FBF3458-DED1-4246-95A2-AA988B5584F1 Q36929881-68A8FA9E-8C24-4CDD-8D9E-9F544BEE6C5E Q37038637-1894EC6D-76D8-4C8C-8372-5F294BB6E92F Q38646305-DA8E3BC6-0DBD-4C0C-8E8E-E5EA58F635EA Q38885442-27B27ECD-7D7F-450E-B170-07CC5D9038F2 Q41127275-55A183D9-99BF-4E4A-9B93-17A29B2E8B41 Q42368784-67BFEC68-34A9-48A8-8667-05006B42BABD Q46756406-135E2BA1-4F26-4546-BF8C-E54E32EB62D6 Q47548720-423222E4-FFC0-4AAF-A856-1C1B41348F3C Q47744330-3ED95F78-11C2-4ECB-9AB1-4548B4A14C81 Q48264269-70B7C422-FAAF-4AD1-9A33-CF798A7B3257 Q50174779-0ECFF61B-F013-459A-BC7F-48F0D758DB3D Q57257331-725A2E31-B5F7-4EC6-A9FB-C066A9A25EE2

P2860

Tuberous Sclerosis: A New Frontier in Targeted Treatment of Autism

http://www.wikidata.org/entity/Q35811772

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Tuberous Sclerosis: A New Frontier in Targeted Treatment of Autism

@ast

Tuberous Sclerosis: A New Frontier in Targeted Treatment of Autism

@en

type

label

Tuberous Sclerosis: A New Frontier in Targeted Treatment of Autism

@ast

Tuberous Sclerosis: A New Frontier in Targeted Treatment of Autism

@en

prefLabel

Tuberous Sclerosis: A New Frontier in Targeted Treatment of Autism

@ast

Tuberous Sclerosis: A New Frontier in Targeted Treatment of Autism

@en

P1433

Q35811772-8BE11725-1531-46F9-99DD-079F3558E12F

P1476

Q35811772-7E89865B-8C01-46AA-AA0B-967D354E41D4

P2093

Q35811772-6D7D4502-7E72-4906-ABD7-069C7E8611F4

Q35811772-E8809323-B2DF-43F4-A7B8-7090EFAACDE9

P2860

Q35811772-0B4A9045-4887-419B-9FE2-89DF5E931DFC

Q35811772-0BCA8354-7BD7-41F9-984E-8EFBFC707383

Q35811772-0D699469-9060-43A2-87A2-682136AEDC84

Q35811772-0E0E75CC-3EAF-40D7-A22C-7FDE46401E5D

Q35811772-11FD11DB-E329-43BD-8E98-E54EF6F6229D

Q35811772-156AA710-60B9-431D-B09E-84022196B0E9

Q35811772-18F77E11-6349-4B20-B642-0D5626AB2C0B

Q35811772-19984F6F-2A4E-432A-936A-7E7CA23CB066

Q35811772-1D165120-9C8E-43E6-85F4-D4E636FBB90A

Q35811772-1D8C28EE-F6F2-4448-A708-F48F12DAF3D7

P2888

Q35811772-396EDD6A-8133-40F7-96B0-38131B68B29E

P304

Q35811772-1AB5EC51-20AD-4A27-A426-582F91956B56

P31

Q35811772-8AD65CC9-C3B0-48C5-8EBE-7A7C134B152E

P356

Q35811772-84C161CE-BE44-4C3E-A4D7-C7947C0356DE

P433

Q35811772-8CD83873-0816-4456-91D5-A6D98F5464DD

P478

Q35811772-B4F794EC-52F2-4532-9FD9-70524A839F98

P50

Q35811772-39C18D64-CFFB-434A-8D4F-AA4D8E16BDB8

Q35811772-8AC024E6-2507-4DB2-B1C6-58EC388C5B62

P577

Q35811772-A222DD77-2CDB-49CF-86A9-6C9B2906B300

P698

Q35811772-634F24B6-5C8B-4553-9198-3D9C5935B4BE

P921

Q35811772-233F3C01-6728-40F9-9ECB-6A37DC6897BD

P932

Q35811772-FB993DE8-7595-4C5E-B200-DC8216171EC5

P356

S13311-015-0359-5

P1433

Neurotherapeutics

P1476

Tuberous Sclerosis: A New Frontier in Targeted Treatment of Autism

@en

P2093

Darcy A Krueger

http://www.w3.org/2001/XMLSchema#string

Jurriaan M Peters

http://www.w3.org/2001/XMLSchema#string

P2860

Brain functional networks in syndromic and non-syndromic autism: a graph theoretical study of EEG connectivity.

The Autistic Neuron: Troubled Translation?

Efficacy and safety of sirolimus in lymphangioleiomyomatosis.

mTOR signaling in growth control and disease

mTOR signaling: at the crossroads of plasticity, memory and disease

Reversal of learning deficits in a Tsc2+/- mouse model of tuberous sclerosis

The neurology of mTOR

Seizure-dependent mTOR activation in 5-HT neurons promotes autism-like behaviors in mice

Loss of mTOR-dependent macroautophagy causes autistic-like synaptic pruning deficits

Rapamycin causes regression of astrocytomas in tuberous sclerosis complex

P2888

s13311-015-0359-5

P304

572-583

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S13311-015-0359-5

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25986747

http://www.w3.org/2001/XMLSchema#string

P921

P932

4489948

http://www.w3.org/2001/XMLSchema#string